ATA10689A - Didesoxydehydrocarbocyclische nucleoside und deren verwendung - Google Patents

Didesoxydehydrocarbocyclische nucleoside und deren verwendung

Info

Publication number
ATA10689A
ATA10689A AT0010689A AT10689A ATA10689A AT A10689 A ATA10689 A AT A10689A AT 0010689 A AT0010689 A AT 0010689A AT 10689 A AT10689 A AT 10689A AT A10689 A ATA10689 A AT A10689A
Authority
AT
Austria
Prior art keywords
didesoxydehydrocarbocyclic
nucleosides
didesoxydehydrocarbocyclic nucleosides
Prior art date
Application number
AT0010689A
Other languages
English (en)
Other versions
AT397801B (de
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/146,252 external-priority patent/US4916224A/en
Priority claimed from GB888821011A external-priority patent/GB8821011D0/en
Priority claimed from US07/278,652 external-priority patent/US4931559A/en
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of ATA10689A publication Critical patent/ATA10689A/de
Application granted granted Critical
Publication of AT397801B publication Critical patent/AT397801B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT0010689A 1988-01-20 1989-01-19 Didesoxydehydrocarbocyclische nucleoside und deren verwendung AT397801B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/146,252 US4916224A (en) 1988-01-20 1988-01-20 Dideoxycarbocyclic nucleosides
GB888821011A GB8821011D0 (en) 1988-09-07 1988-09-07 Chemical compounds
US07/278,652 US4931559A (en) 1988-01-20 1988-12-05 Optically-active isomers of dideoxycarbocyclic nucleosides

Publications (2)

Publication Number Publication Date
ATA10689A true ATA10689A (de) 1993-11-15
AT397801B AT397801B (de) 1994-07-25

Family

ID=27264063

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0010689A AT397801B (de) 1988-01-20 1989-01-19 Didesoxydehydrocarbocyclische nucleoside und deren verwendung

Country Status (29)

Country Link
JP (1) JP2793825B2 (de)
KR (1) KR0127137B1 (de)
AT (1) AT397801B (de)
AU (2) AU626278B2 (de)
BE (1) BE1003815A4 (de)
CA (1) CA1339896C (de)
CH (1) CH679152A5 (de)
DE (1) DE3901502C2 (de)
DK (1) DK175131B1 (de)
ES (1) ES2010091A6 (de)
FI (1) FI93546C (de)
FR (1) FR2626002B1 (de)
GB (1) GB2217320B (de)
GR (1) GR890100033A (de)
HU (1) HU203755B (de)
IE (1) IE62275B1 (de)
IL (1) IL88999A (de)
IT (1) IT1229531B (de)
LU (1) LU87437A1 (de)
MY (1) MY103801A (de)
NL (1) NL8900122A (de)
NO (1) NO169123C (de)
NZ (1) NZ227663A (de)
OA (1) OA09031A (de)
PL (1) PL163814B1 (de)
PT (1) PT89482B (de)
RU (1) RU2114846C1 (de)
SE (1) SE505213C2 (de)
YU (1) YU47791B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
DK0479822T3 (da) * 1989-06-27 2000-03-20 Wellcome Found Terapeutiske nucleosider
GB8916479D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916477D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916480D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916478D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5241069A (en) * 1990-04-06 1993-08-31 Glaxo Inc. Carbonate intermediates for the synthesis of purine substituted cyclopentene derivatives
US5144034A (en) * 1990-04-06 1992-09-01 Glaxo Inc. Process for the synthesis of cyclopentene derivatives of purines
US5057630A (en) * 1990-04-06 1991-10-15 Glaxo Inc. Synthesis of cyclopentene derivatives
GB9108376D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Cyclopentenes
JPH09509397A (ja) * 1993-11-12 1997-09-22 メレルファーマス−ティカルズ インコーポレイテッド 免疫抑制剤として有用な６−オキソ−ヌクレオシド類
GB9721780D0 (en) * 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
CN1115338C (zh) * 1998-10-30 2003-07-23 隆萨股份公司 4－[(2′,5′－二氨基－6′－卤代嘧啶－4′－基)氨基]－环戊－2－烯基甲醇的制备方法
US6433170B1 (en) 1998-10-30 2002-08-13 Lonza Group Method for producing 4-[2',5'-diamino-6'-halopyrimidine-4'-yl)amino]- cyclopent-2-enylmethanols
TWI229674B (en) * 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
AR039540A1 (es) 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
TW202019942A (zh) 2018-07-27 2020-06-01 日商富士軟片股份有限公司 環戊烯嘌呤衍生物或其鹽
EP4125840A1 (de) 2020-03-27 2023-02-08 Som Innovation Biotech, S.A. Verbindungen zur verwendung bei der behandlung von synukleinopathien

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
JPS62177234A (ja) * 1986-01-30 1987-08-04 Mitsubishi Heavy Ind Ltd 遠心紡糸によるカ−ボン繊維の製造装置
IN164556B (de) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.

Also Published As

Publication number Publication date
IE890153L (en) 1989-07-20
IL88999A (en) 1994-12-29
GR890100033A (el) 1994-03-31
FI93546C (fi) 1995-04-25
GB2217320B (en) 1992-04-08
IT8947546A0 (it) 1989-01-19
SE8900192L (sv) 1989-07-21
NO169123C (no) 1992-05-13
DK23489A (da) 1989-07-21
AU626278B2 (en) 1992-07-30
HUT48887A (en) 1989-07-28
PL277261A1 (en) 1989-09-18
RU2114846C1 (ru) 1998-07-10
CH679152A5 (de) 1991-12-31
AU637015B2 (en) 1993-05-13
GB8901187D0 (en) 1989-03-15
YU47791B (sr) 1996-01-09
NO169123B (no) 1992-02-03
MY103801A (en) 1993-09-30
NO890253L (no) 1989-07-21
AU1018092A (en) 1992-03-12
AT397801B (de) 1994-07-25
BE1003815A4 (fr) 1992-06-23
DE3901502A1 (de) 1989-07-27
LU87437A1 (fr) 1989-08-30
IL88999A0 (en) 1989-08-15
FR2626002A1 (fr) 1989-07-21
CA1339896C (en) 1998-06-02
IE62275B1 (en) 1995-01-25
FI93546B (fi) 1995-01-13
HU203755B (en) 1991-09-30
FI890286A0 (fi) 1989-01-19
YU12389A (en) 1991-10-31
IT1229531B (it) 1991-09-04
PL163814B1 (en) 1994-05-31
JP2793825B2 (ja) 1998-09-03
DK175131B1 (da) 2004-06-14
KR0127137B1 (ko) 1997-12-29
DK23489D0 (da) 1989-01-19
KR890011902A (ko) 1989-08-23
NL8900122A (nl) 1989-08-16
NO890253D0 (no) 1989-01-19
AU2867189A (en) 1989-07-20
ES2010091A6 (es) 1989-10-16
SE505213C2 (sv) 1997-07-14
DE3901502C2 (de) 2002-06-13
PT89482B (pt) 1994-02-28
JPH02196788A (ja) 1990-08-03
NZ227663A (en) 1990-09-26
OA09031A (en) 1991-03-31
FR2626002B1 (fr) 1994-01-28
FI890286A (fi) 1989-07-21
PT89482A (pt) 1989-10-04
GB2217320A (en) 1989-10-25
SE8900192D0 (sv) 1989-01-19

Similar Documents

Publication Publication Date Title
ATA10689A (de) Didesoxydehydrocarbocyclische nucleoside und deren verwendung
LV5781A4 (lv) Arstnieciski nukleozidi
DE68921469T2 (de) Peptidderivate und deren verwendung.
DE3786205D1 (de) Titanocene und deren verwendung.
DE3582399D1 (de) Purin-derivate und ihre pharmazeutische verwendung.
DK604087D0 (da) Phosphonomethoxyalkylenpurin og pyrimidinderivater deraf
DE19575021I2 (de) Therapeutische Nucleoside
DE68929304T2 (de) Oligoribonukleotid-Derivate und Verwendung davon als Antiviral-Arzneimittel
DE58904478D1 (de) Strahlungsempfindliche gemische und deren verwendung.
DE3677206D1 (de) D-luciferin-derivate und deren verwendung.
DE3784199D1 (de) Titanocene und deren verwendung.
DK297988D0 (da) Antihyperlipidemisk og antiatheroscelotisk virksomme urinstof- og carbamatderivater
KR900701711A (ko) 퍼플루오로아세탈과 퍼플루오로케탈 화합물 및 열충격 시험에서의 그것의 용도
DK564088D0 (da) Nukleosidderivater
ATA213188A (de) Wasserverduennbare lufttrocknende beschichtungsmittel und deren verwendung
DE3688864D1 (de) L-phenylalanindehydrogenase und deren verwendung.
IT8422739A0 (it) Derivati nucleosidici e purinici 8-sostituiti.
DE3766441D1 (de) Anilinotriazine und deren verwendung.
DE68914750D1 (de) Therapeutische Nucleoside.
DK626989D0 (da) Adenosinderivater
DE3854981T2 (de) 1-Pyrrolidinacetamid-Derivate und ihre Verwendung
DE3668173D1 (de) Anthracyclinderivate und deren verwendung.
DE3868608D1 (de) Organozinn-alkoxycarbonylphenylmercaptide und deren verwendung.
DK280089A (da) Antiinfektive nucleosider
DE69012142D1 (de) Acylierte bradykininantagonisten und deren verwendung.

Legal Events

Date Code Title Description
ELA Expired due to lapse of time